About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT00572247

The Psychiatric Rehabilitation Approach to Weight Loss

The primary aim of the project is to examine the efficacy of the Psychiatric Rehabilitation Weight Loss program in reduction of weight and body mass index (BMI.

Lead sponsor: University of Kansas•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Kansas

Collaborators

National Institute of Mental Health (NIMH)

The study involves 144 individuals who will be randomly assigned to the intervention group or treatment as usual group(control group). All Participants will undergo baseline assessment, assessment at week 12, week 24 and in year from baseline.

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•A diagnosis of serious mental illness,
•Age 18 - 65
•BMI \> 25
•Medication stable (there have been no changes in antipsychotic medications or mood stabilizers for the last 3 months).

Exclusion Criteria

•Current or history of eating disorder
•Pregnant or breast feeding
•Uncontrolled HTN
•Severe coronary artery disease
•Severe valvular disease
•Uncontrolled diabetes
•Sustained arrhythmia
•Insulin using severe physical limitations
•Severe Lung Disorders
•Diagnosis of MR or dementia

Related studies

COMPLETEDPhase 1

A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia

NCT01606436 · Schizophrenic Disorders

Have a Good Grasp of the Worldthe World

NCT02655172 · Schizophrenic Disorders

COMPLETEDPhase 3

Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

NCT00488319 · Schizophrenia, Schizophrenic Disorders, and more

Upside Down, Give me the Handle

NCT02544516 · Schizophrenic Disorders

Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor)

NCT01729650 · Schizophrenic Disorders, Schizoaffective Disorders, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 7, 2012Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment133

Start dateJan 2007

Last updatedMar 7, 2012

Condition

Schizophrenic Disorders

Locations shown

University of Kansas Medical Center

Kansas City, Kansas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 7, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions